Hi Foros.
Proximly, I have an appointment with the endocrine to give me the results of the analytics.Before talking to him, I advance, consulting you a feared.
It seems that diamyd trials are in phase III.I would like to know according to your experience, if it would be appropriate to be the same endocrine that recruited the patient to participate in this type of trial, whether it is type 1, as if it is type 1.5, (lada).Or, the one who wants to participate in according to what study, is it on other ways?And another thing, is it necessary to be insulin of the dependent to enter these essays?
And according to your opinion, diamyd as a treatment, (in pills or in injections-no idea of how it is administered), it is already a reality, that is, these types of patients, could be excited but with healing, yes with a quasi control-Perfect of your glycemia?.
At the level of treatments I see it, (at least as they paint it on paper), as the next step to the insulin that is marketed today.Although both types of drugs had to be combined, according to the results of phase II, it seems that blood glucose would be more "easy" to control, right?
greetings